<産業資料/調査レポートの題名> 2022年7月19日

喘息用スペーサーの世界市場2019-2023


◆英文タイトル:Global Asthma Spacers Market 2019-2023

PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
• 2.1 Preface
• 2.2 Preface
• 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 04: MARKET SIZING
• Market definition
• Market sizing 2018
• Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 06: MARKET SEGMENTATION BY DISTRIBUTION CHANNEL
• Market segmentation by distribution channel
• Comparison by distribution channel
• Hospital and retail pharmacies – Market size and forecast 2018-2023
• Online stores – Market size and forecast 2018-2023
• Market opportunity by distribution channel
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
• Geographic segmentation
• Geographic comparison
• Americas – Market size and forecast 2018-2023
• EMEA – Market size and forecast 2018-2023
• APAC – Market size and forecast 2018-2023
• Key leading countries
• Market opportunity
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 11: MARKET TRENDS
• Growing strategic alliances
• Increase in online retailing
• Growing initiatives toward respiratory diseases
PART 12: VENDOR LANDSCAPE
• Overview
• Landscape disruption
PART 13: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• ALLERGAN
• Cipla
• Koninklijke Philips
• LUPIN
• Medical Developments International
PART 14: APPENDIX
• Research methodology
• List of abbreviations
PART 15: EXPLORE TECHNAVIO


Exhibit 01: Global medical devices market
Exhibit 02: Segments of global medical devices market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition – Inclusions and exclusions checklist
Exhibit 06: Market size 2018
Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 09: Five forces analysis 2018
Exhibit 10: Five forces analysis 2023
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition – Five forces 2018
Exhibit 17: Distribution channel – Market share 2018-2023 (%)
Exhibit 18: Comparison by distribution channel
Exhibit 19: Hospital and retail pharmacies – Market size and forecast 2018-2023 ($ millions)
Exhibit 20: Hospital and retail pharmacies – Year-over-year growth 2019-2023 (%)
Exhibit 21: Online stores – Market size and forecast 2018-2023 ($ millions)
Exhibit 22: Online stores – Year-over-year growth 2019-2023 (%)
Exhibit 23: Market opportunity by distribution channel
Exhibit 24: Customer landscape
Exhibit 25: Market share by geography 2018-2023 (%)
Exhibit 26: Geographic comparison
Exhibit 27: Americas – Market size and forecast 2018-2023 ($ millions)
Exhibit 28: Americas – Year-over-year growth 2019-2023 (%)
Exhibit 29: EMEA – Market size and forecast 2018-2023 ($ millions)
Exhibit 30: EMEA – Year-over-year growth 2019-2023 (%)
Exhibit 31: APAC – Market size and forecast 2018-2023 ($ millions)
Exhibit 32: APAC – Year-over-year growth 2019-2023 (%)
Exhibit 33: Key leading countries
Exhibit 34: Market opportunity
Exhibit 35: Rise in population aged 65 years and above (% of total)
Exhibit 36: Impact of drivers and challenges
Exhibit 37: Vendor landscape
Exhibit 38: Landscape disruption
Exhibit 39: Vendors covered
Exhibit 40: Vendor classification
Exhibit 41: Market positioning of vendors
Exhibit 42: ALLERGAN – Vendor overview
Exhibit 43: ALLERGAN – Business segments
Exhibit 44: ALLERGAN – Organizational developments
Exhibit 45: ALLERGAN – Geographic focus
Exhibit 46: ALLERGAN – Segment focus
Exhibit 47: ALLERGAN – Key offerings
Exhibit 48: Cipla – Vendor overview
Exhibit 49: Cipla – Business segments
Exhibit 50: Cipla – Organizational developments
Exhibit 51: Cipla – Geographic focus
Exhibit 52: Cipla – Segment focus
Exhibit 53: Cipla – Key offerings
Exhibit 54: Koninklijke Philips – Vendor overview
Exhibit 55: Koninklijke Philips – Business segments
Exhibit 56: Koninklijke Philips – Organizational developments
Exhibit 57: Koninklijke Philips – Geographic focus
Exhibit 58: Koninklijke Philips – Segment focus
Exhibit 59: Koninklijke Philips – Key offerings
Exhibit 60: LUPIN – Vendor overview
Exhibit 61: LUPIN – Business segments
Exhibit 62: LUPIN – Organizational developments
Exhibit 63: LUPIN – Geographic focus
Exhibit 64: LUPIN – Key offerings
Exhibit 65: Medical Developments International – Vendor overview
Exhibit 66: Medical Developments International – Business segments
Exhibit 67: Medical Developments International – Organizational developments
Exhibit 68: Medical Developments International – Geographic focus
Exhibit 69: Medical Developments International – Segment focus
Exhibit 70: Medical Developments International – Key offerings
Exhibit 71: Validation techniques employed for market sizing


LINEで送る
Share on LinkedIn
このエントリーをはてなブックマークに追加
Bookmark this on BuzzURL
Bookmark this on Yahoo Bookmark